News
-
-
-
-
PRESS RELEASE
Mainz Biomed Receives Swiss Regulatory Approval to Market ColoAlert®
Mainz Biomed receives Swiss regulatory approval to market ColoAlert®, a non-invasive colorectal cancer screening test, following partnership with a local laboratory. The test aims to improve participation rates in CRC screening programs -
-
-
-
PRESS RELEASE
Mainz Biomed Half Year 2025 Update: Accelerating FDA Pathway for NextGen Colorectal Cancer Screening and Expansion with Pancreatic Cancer Screening Acquisition
Mainz Biomed provides Half Year 2025 update, accelerating FDA pathway for NextGen Colorectal Cancer Screening and expanding with Pancreatic Cancer Screening Acquisition -
-